Taiwan FDA registration b5aeb6b681e10907858c26b5396eed46
Hyabell Ultra
TW: 艾玻豐潤(含利多卡因)
Taiwan·Risk Class 3·MD·ADODERM GMBH·Registered Dec 14, 2022 – Dec 14, 2027ActiveRegistration details
- Analysis ID
- b5aeb6b681e10907858c26b5396eed46
- License Form
- Ministry of Health Medical Device Import No. 036136
- Customs Code
- DHA05603613600
Company information
- Manufacturer
- ADODERM GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- ORIENT EUROPHARMA CO., LTD.
Product details
- Intended Use
- HYABELL ULTRA IS AN INJECTABLE FILLER SUITABLE FOR TREATING DEEP SKIN HOLLOWS ON THE FACE (LIMITED TO CHEEKBONES, CHEEKS AND CHIN) AND TO ADD OR RESTORE TISSUE VOLUME. The use of lidocaine hydrochloride is to reduce pain during injection.
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I0007 Hyaluronic acid implants
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 14, 2022
- Expiry Date
- Dec 14, 2027
About this record
Access comprehensive regulatory information for Hyabell Ultra in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b5aeb6b681e10907858c26b5396eed46 and manufactured by ADODERM GMBH. The authorized representative in Taiwan is ORIENT EUROPHARMA CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices